BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19465042)

  • 1. Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells.
    Charoensuk V; Gati WP; Weinfeld M; Le XC
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):64-70. PubMed ID: 19465042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z; Zhou J; Lu X; Gong Z; Le XC
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Guo S; Wang X; Gao C; Wu Z; Chen H; Lin L; Guo M; Gao Y; Hai X
    Toxicol Lett; 2021 Sep; 347():78-85. PubMed ID: 33865921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing.
    Moe B; Peng H; Lu X; Chen B; Chen LWL; Gabos S; Li XF; Le XC
    J Environ Sci (China); 2016 Nov; 49():113-124. PubMed ID: 28007166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species.
    Rehman K; Fu YJ; Zhang YF; Wang QQ; Wu B; Wu Y; Zhou XY; Sun WH; Sun TF; Naranmandura H
    Metallomics; 2014 Aug; 6(8):1502-12. PubMed ID: 24870979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Šlejkovec Z; Podgornik H; Černelč P; Falnoga I
    Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arsenic compounds on growth, cell-cycle distribution and apoptosis of tretinoin-resistant human promyelocytic leukemia cells.
    Sakai C; Arai M; Tanaka S; Onda K; Sugiyama K; Hirano T
    Anticancer Res; 2014 Nov; 34(11):6489-94. PubMed ID: 25368250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation and methylation status determine the effects of arsenic on the mitotic apparatus.
    Kligerman AD; Doerr CL; Tennant AH
    Mol Cell Biochem; 2005 Nov; 279(1-2):113-21. PubMed ID: 16283520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients.
    Lv J; Wu M; Pang C; Duan R; Zhang H; Tian S; Yang H; Hai X
    Biomed Pharmacother; 2023 Jul; 163():114858. PubMed ID: 37172335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
    Guo M; Zhao Q; Fan S; Wu Z; Lin L; Chen H; Gao Y; Hai X
    Br J Clin Pharmacol; 2021 Oct; 87(10):4020-4026. PubMed ID: 33638869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment.
    Chen B; Cao F; Lu X; Shen S; Zhou J; Le XC
    Talanta; 2018 Jul; 184():446-451. PubMed ID: 29674067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Gao C; Lin L; Li J; Wu M; Lv J; Tian S; Hai X
    Toxicol Lett; 2023 May; 380():31-39. PubMed ID: 37024065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.
    Xu S; Zhang YF; Carew MW; Hao WH; Loo JF; Naranmandura H; Le XC
    Arch Toxicol; 2013 Jun; 87(6):1013-23. PubMed ID: 23052202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.